Compare ANIX & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIX | AKA |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.6M | 113.4M |
| IPO Year | 2013 | 2021 |
| Metric | ANIX | AKA |
|---|---|---|
| Price | $2.97 | $11.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 113.0K | 3.0K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $600,208,000.00 |
| Revenue This Year | N/A | $6.14 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.44 |
| 52 Week Low | $2.44 | $8.60 |
| 52 Week High | $5.46 | $16.38 |
| Indicator | ANIX | AKA |
|---|---|---|
| Relative Strength Index (RSI) | 51.78 | 63.07 |
| Support Level | $2.74 | $10.51 |
| Resistance Level | $3.11 | $11.75 |
| Average True Range (ATR) | 0.18 | 0.59 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 36.88 | 86.35 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.